E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Add to balance / Manage account  User:  Log out
Prospect News home > News index > List of issuers B > Headlines for BioDelivery Sciences International, Inc. > News item
Published on 7/17/2009 in the Prospect News Special Situations Daily.

BioDelivery Sciences investor Elliott Associates trims stake to 12.3%

By Susanna Moon

Chicago, July 17 - Elliott Associates, LP sold 210,063 shares of BioDelivery Sciences International, Inc. between July 7 and July 16 at prices from $6.00 to $7.17 each, according to a schedule 13D/A filed on Monday with the Securities and Exchange Commission.

The investors beneficially own 2,665,350 shares or 12.3% of the Morrisville, N.C.-based pharmaceutical company.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.